Annual Working Capital
$739.83 M
-$215.96 M-22.59%
December 31, 2023
Summary
- As of February 7, 2025, RLAY annual working capital is $739.83 million, with the most recent change of -$215.96 million (-22.59%) on December 31, 2023.
- During the last 3 years, RLAY annual working capital has fallen by -$16.63 million (-2.20%).
- RLAY annual working capital is now -22.59% below its all-time high of $955.80 million, reached on December 31, 2022.
Performance
RLAY Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$818.16 M
+$158.93 M+24.11%
September 1, 2024
Summary
- As of February 7, 2025, RLAY quarterly working capital is $818.16 million, with the most recent change of +$158.93 million (+24.11%) on September 1, 2024.
- Over the past year, RLAY quarterly working capital has increased by +$37.11 million (+4.75%).
- RLAY quarterly working capital is now -19.46% below its all-time high of $1.02 billion, reached on September 30, 2022.
Performance
RLAY Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
RLAY Working Capital Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -22.6% | +4.8% |
3 y3 years | -2.2% | +34.0% |
5 y5 years | +77.3% | - |
RLAY Working Capital Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -22.6% | at low | -19.5% | +24.1% |
5 y | 5-year | -22.6% | +112.3% | -19.5% | +169.9% |
alltime | all time | -22.6% | +112.3% | -19.5% | +169.9% |
Relay Therapeutics Working Capital History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $818.16 M(+24.1%) |
Jun 2024 | - | $659.23 M(-10.1%) |
Mar 2024 | - | $732.96 M(-0.9%) |
Dec 2023 | $739.83 M(-22.6%) | $739.83 M(-5.3%) |
Sep 2023 | - | $781.05 M(-3.9%) |
Jun 2023 | - | $812.77 M(-8.5%) |
Mar 2023 | - | $887.92 M(-7.1%) |
Dec 2022 | $955.80 M | $955.80 M(-5.9%) |
Sep 2022 | - | $1.02 B(+25.1%) |
Jun 2022 | - | $811.89 M(-7.1%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2022 | - | $874.10 M(-8.2%) |
Dec 2021 | $951.92 M(+25.8%) | $951.92 M(+55.9%) |
Sep 2021 | - | $610.74 M(-6.9%) |
Jun 2021 | - | $655.89 M(-9.7%) |
Mar 2021 | - | $726.35 M(-4.0%) |
Dec 2020 | $756.47 M(+117.0%) | $756.47 M(+7.1%) |
Sep 2020 | - | $706.18 M(+133.0%) |
Jun 2020 | - | $303.10 M(-7.3%) |
Mar 2020 | - | $327.12 M(-6.1%) |
Dec 2019 | $348.55 M(-16.5%) | $348.55 M |
Dec 2018 | $417.24 M | - |
FAQ
- What is Relay Therapeutics annual working capital?
- What is the all time high annual working capital for Relay Therapeutics?
- What is Relay Therapeutics annual working capital year-on-year change?
- What is Relay Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Relay Therapeutics?
- What is Relay Therapeutics quarterly working capital year-on-year change?
What is Relay Therapeutics annual working capital?
The current annual working capital of RLAY is $739.83 M
What is the all time high annual working capital for Relay Therapeutics?
Relay Therapeutics all-time high annual working capital is $955.80 M
What is Relay Therapeutics annual working capital year-on-year change?
Over the past year, RLAY annual working capital has changed by -$215.96 M (-22.59%)
What is Relay Therapeutics quarterly working capital?
The current quarterly working capital of RLAY is $818.16 M
What is the all time high quarterly working capital for Relay Therapeutics?
Relay Therapeutics all-time high quarterly working capital is $1.02 B
What is Relay Therapeutics quarterly working capital year-on-year change?
Over the past year, RLAY quarterly working capital has changed by +$37.11 M (+4.75%)